Net Income (TTM) Chart

View Net Income (TTM) for AKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (TTM) Chart
Start Trial

Historical Net Income (TTM) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 -30.90M
March 31, 2026 -28.00M
December 31, 2025 -17.27M
September 30, 2025 -15.72M
June 30, 2025 -12.26M
March 31, 2025 -17.90M
December 31, 2024 -19.76M
September 30, 2024 -15.02M
June 30, 2024 -17.80M
March 31, 2024 -15.42M
March 31, 2023 -15.64M
June 30, 2022 -18.10M
March 31, 2022 -16.76M
December 31, 2021 -17.42M
September 30, 2021 -18.46M
June 30, 2021 -16.09M
March 31, 2021 -19.19M
December 31, 2020 -17.09M
September 30, 2020 -18.15M
June 30, 2020 -21.63M
Date Value
March 31, 2020 -18.31M
December 31, 2019 -17.11M
September 30, 2019 -12.74M
June 30, 2019 -13.77M
March 31, 2019 -17.67M
December 31, 2018 -16.47M
September 30, 2018 -22.25M
June 30, 2018 -29.03M
March 31, 2018 -21.33M
December 31, 2017 -32.57M
September 30, 2017 -30.87M
June 30, 2017 -20.91M
March 31, 2017 -27.04M
December 31, 2016 -17.29M
September 30, 2016 -3.279M
June 30, 2016 -51.71M
March 31, 2016 -46.88M
December 31, 2015 -46.22M
September 30, 2015 -54.03M
June 30, 2015 -4.767M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (TTM) Range, Past 5 Years

View Net Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (TTM) Benchmarks

View Net Income (TTM) Benchmarks
Start Trial
DBV Technologies SA --
Cellectis SA -65.33M
argenx SE 1.714B
Autolus Therapeutics Plc -279.49M
Evaxion AS -8.683M